Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

BACKGROUND: Waldenström macroglobulinemia (WM) is preceded by asymptomatic WM (AWM), for which the risk of progression to overt disease is not well defined. METHODS: We studied 439 patients with AWM, who were diagnosed and observed at Dana-Farber Cancer Institute between 1992 and 2014. RESULTS: Duri...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Oncol
Huvudupphovsmän: Bustoros, Mark, Sklavenitis-Pistofidis, Romanos, Kapoor, Prashant, Liu, Chia-Jen, Kastritis, Efstathios, Zanwar, Saurabh, Fell, Geoffrey, Abeykoon, Jithma P., Hornburg, Kalvis, Neuse, Carl Jannes, Marinac, Catherine R., Liu, David, Soiffer, Jenny, Gavriatopoulou, Maria, Boehner, Cody, Cappuccio, Joseph M., Dumke, Henry, Reyes, Kaitlen, Soiffer, Robert J., Kyle, Robert A., Treon, Steven P., Castillo, Jorge J., Dimopoulos, Meletios A., Ansell, Stephen M., Trippa, Lorenzo, Ghobrial, Irene M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2019
Ämnen:
ORIGINAL REPORTS
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544461/
https://ncbi.nlm.nih.gov/pubmed/30990729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00394
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk